Li et al reported scores for predicting the risk of venous thromboembolism (VTE) in a patient with lung cancer. The authors are from the First Affiliated Hospital of Sun Yat-sen University and the First Affiliated Hospital of Guangzhou Medical University in China.
Patient selection: lung cancer
Parameters:
(1) sex
(2) age in years
(3) clinical stage
(4) histology
(5) history of chemotherapy
(6) history of surgery (presumed lung tumor related)
(7) D-dimer in mg/L FEU
(8) history of central venous catheter (presumed recent)
Parameter |
Finding |
Points |
Beta-Coefficient |
sex |
female |
0 |
0 |
|
male |
1 |
0.927 |
age in years |
< 65 years |
0 |
0 |
|
>= 65 years |
1 |
0.818 |
clinical stage |
I or II |
0 |
0 |
|
III or IV |
1 |
0.675 |
histology |
adenocarcinoma |
1 |
0.837 |
|
other |
0 |
0 |
chemotherapy |
no |
0 |
0 |
|
yes |
1 |
0.945 |
surgery |
no |
0 |
0 |
|
yes |
1 |
0.740 |
D-dimer |
<= 0.55 mg/L |
0 |
0 |
|
> 0.55 mg/L |
1 |
0.679 |
CVC |
no |
0 |
0 |
|
yes |
2 |
1.519 |
total score using points =
= SUM(points for all 8 parameters)
X score =
= SUM(beta-coefficients for all 8 parameters) - 5.879
probability of VTE =
= 1 / (1 + EXP((-1) * X))
Interpretation:
• minimum total score: 0
• maximum total score: 9
Total Score |
Risk |
0 to 3 |
low |
4 or 5 |
moderate |
6 to 9 |
high |
Performance:
• The area under the ROC curve was 0.82 for the development and 0.83 for the validation cohorts.
Specialty: Hematology Oncology